Table 4.
Diabetes | No Diabetes | |
---|---|---|
Events/N | 11/86 | 87/655 |
Mean IGF-1(SD) | 152.08(66.35) | 144.34(59.22) |
Age and sex adjusted* | 0.39 [0.20, 0.78] (0.007) | 0.88 [0.69, 1.11] (0.277) |
Multivariate † | 0.42 [0.22, 0.79] (0.007) | 0.91 [0.72, 1.16] (0.451) |
Multivariate+Mediators‡ | 0.40 [0.20, 0.81] (0.011) | 0.96 [0.77, 1.21] (0.756) |
Hazard ratios, HR [95% CI], (p-values) are estimated for 1 SD (standard deviation) increase in IGF-1 levels in each category.
P-value for interaction = 0.016
HR: Hazard ratio; CI: Confidence interval; SD: Standard deviation; N: Number of observations, IS: Ischemic stroke.
Adjusted for age, sex, systolic blood pressure, smoking, anti-hypertensive treatment, prevalent CVD.
Additionally adjusted for waist-hip ratio and atrial fibrillation.